Epidemiology and Antimicrobial Resistance of Stenotrophomonas maltophilia in China, 2014–2021
This study highlights the stable prevalence of S. maltophilia in clinical settings in China and the overall low resistance rates to recommended first-line antibiotics. However, alarmingly high resistance rates were observed in specific specimen types, particularly in blood cultures, suggesting that minocycline may be the only reliable therapeutic option among the six tested antibiotics for treating such infections in China. Continuous surveillance and effective infection control measures are essential to manage S. maltophilia infections, particularly in vulnerable populations. Future research should focus on measuring the true burden of these infections and monitoring the susceptibility of the newly introduced antibiotics, such as cefiderocol.
Authors
- Shu Zhou (ORCID: https://orcid.org/0000-0002-9138-477X)
- Yusheng Cheng (ORCID: https://orcid.org/0000-0003-0044-005X)
- Xingwu Chen (ORCID: https://orcid.org/0000-0002-1450-0503)
- Lei Zha (ORCID: https://orcid.org/0000-0003-4897-0703)
- Qinghai You (ORCID: https://orcid.org/0000-0002-6237-9146)
- Hanli Wang (ORCID: https://orcid.org/0009-0007-6839-9344)
- Zhiwei Lü (ORCID: https://orcid.org/0000-0003-1503-4126)
- Shirong Li (ORCID: https://orcid.org/0009-0008-3509-8585)
- Yixin Hu (ORCID: https://orcid.org/0000-0002-4686-3747)
- Haoyu Ji (ORCID: https://orcid.org/0009-0004-3724-0785)
Institutions
- Anhui Medical University (CN)
- Wuhu No 1 People's Hospital (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- First Affiliated Hospital of Wannan Medical College (CN)
- Xi’an Jiaotong-Liverpool University (CN)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2024-12-28
- DOI
- https://doi.org/10.1007/s40121-024-01099-7
- Citations
- 7
- Primary Topic
- Infections and bacterial resistance
- Type
- article
- Field-Weighted Citation Impact
- 4.32